| Schedule of Segment Information |
The following table provides information about the Company's single operating segment which includes significant expenses by function along with significant non-cash expense items.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
|
Six Months Ended
June 30, |
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
Revenue: |
|
|
|
|
|
|
|
|
|
|
|
Collaboration and license revenue |
$ |
3,076 |
|
|
$ |
536 |
|
|
$ |
5,247 |
|
|
$ |
1,102 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
Research and development: |
|
|
|
|
|
|
|
|
|
|
|
Laboratory supplies, research materials and studies |
|
12,101 |
|
|
|
8,273 |
|
|
|
21,590 |
|
|
|
15,550 |
|
Personnel expenses |
|
8,966 |
|
|
|
7,365 |
|
|
|
17,782 |
|
|
|
15,072 |
|
Facility-related and other |
|
5,657 |
|
|
|
3,949 |
|
|
|
11,205 |
|
|
|
7,851 |
|
Clinical studies |
|
3,721 |
|
|
|
5,121 |
|
|
|
7,416 |
|
|
|
8,954 |
|
Stock-based compensation |
|
1,668 |
|
|
|
1,236 |
|
|
|
3,406 |
|
|
|
2,300 |
|
Depreciation expense |
|
521 |
|
|
|
933 |
|
|
|
1,023 |
|
|
|
2,007 |
|
General and administrative: |
|
|
|
|
|
|
|
|
|
|
|
Personnel expenses |
|
3,337 |
|
|
|
2,623 |
|
|
|
6,356 |
|
|
|
5,291 |
|
Legal and professional fees |
|
2,041 |
|
|
|
2,062 |
|
|
|
3,995 |
|
|
|
3,730 |
|
Facility-related and other |
|
1,935 |
|
|
|
1,812 |
|
|
|
3,743 |
|
|
|
3,459 |
|
Stock-based compensation |
|
1,606 |
|
|
|
1,093 |
|
|
|
3,281 |
|
|
|
2,012 |
|
Depreciation Expense |
|
176 |
|
|
|
183 |
|
|
|
353 |
|
|
|
363 |
|
Loss from operations |
|
(38,653 |
) |
|
|
(34,114 |
) |
|
|
(74,903 |
) |
|
|
(65,487 |
) |
Other (expense) income: |
|
|
|
|
|
|
|
|
|
|
|
Interest and other income, net |
|
2,390 |
|
|
|
3,405 |
|
|
|
5,192 |
|
|
|
5,595 |
|
Interest expense |
|
(689 |
) |
|
|
(952 |
) |
|
|
(1,368 |
) |
|
|
(1,911 |
) |
Net loss |
$ |
(36,952 |
) |
|
$ |
(31,661 |
) |
|
$ |
(71,079 |
) |
|
$ |
(61,803 |
) |
|